文献速递心力衰竭与心肌病

Family Heart Talk沟通工具提高扩张型心肌病患者一级亲属筛查率:随机试验结果

Effectiveness of the Family Heart Talk Communication Tool in Improving Family Member Screening for Dilated Cardiomyopathy: Results of a Randomized Trial.
PubMed 文献 · Circulation · 2023-03-20

本研究开发了Family Heart Talk手册,旨在帮助扩张型心肌病患者向其一级亲属传达遗传风险和心血管筛查需求。在多中心、开放标签、整群随机对照试验中,1241名先证者随机接受手册或常规管理,最终分析显示干预组一级亲属完成筛查的比例为19.5%,对照组为16.0%,调整后OR为1.30(1侧95%CI 1.08-∞),表明手册有效提高了筛查率。

要点

  • Family Heart Talk手册可有效提高DCM患者一级亲属的心血管临床筛查完成率。
  • 干预组筛查完成率19.5%,对照组16.0%,调整后OR=1.30(1侧95%CI 1.08-∞)。
  • 手册可由临床医生在几乎不额外花费时间的情况下提供给患者。

核心结论

  • Family Heart Talk手册能有效提高扩张型心肌病患者一级亲属的心血管临床筛查率。

研究设计与样本

  • 多中心、开放标签、整群随机对照试验,2016年6月至2020年3月随机1241名先证者(1:1)接受手册或对照,按中心和自报种族/族裔分层。
  • 最终分析包括手册组550个家庭(2230名合格一级亲属)和对照组561个家庭(2416名合格一级亲属)。

主要发现

  • 手册组一级亲属完成筛查的比例为19.5%,对照组为16.0%。
  • 调整先证者随机分层、性别和年龄四分位后,手册组一级亲属完成筛查的比值比为1.30(1侧95%CI 1.08-∞)。
  • 预设亚组分析未发现调整后干预比值比在不同种族/族裔分层间存在异质性(P=0.90)。

临床怎么用

  • 临床医生可向DCM患者提供Family Heart Talk手册,以极少的额外时间投入促进其一级亲属接受心血管筛查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Managing disease risk among first-degree relatives of probands diagnosed with a heritable disease is central to precision medicine. A critical component is often clinical screening, which is particularly important for conditions like dilated cardiomyopathy (DCM) that remain asymptomatic until severe disease develops. Nonetheless, probands are frequently ill-equipped to disseminate genetic risk information that motivates at-risk relatives to complete recommended clinical screening. An easily implemented remedy for this key issue has been elusive. METHODS: The DCM Precision Medicine Study developed Family Heart Talk, a booklet designed to help probands with DCM communicate genetic risk and the need for cardiovascular screening to their relatives. The effectiveness of the Family Heart Talk booklet in increasing cardiovascular clinical screening uptake among first-degree relatives was assessed in a multicenter, open-label, cluster-randomized, controlled trial. The primary outcome measured in eligible first-degree relatives was completion of screening initiated within 12 months after proband enrollment. Because probands randomized to the intervention received the booklet at the enrollment visit, eligible first-degree relatives were limited to those who were alive the day after proband enrollment and not enrolled on the same day as the proband. RESULTS: Between June 2016 and March 2020, 1241 probands were randomized (1:1) to receive Family Heart Talk (n=621) or not (n=620) within strata defined by site and self-identified race/ethnicity (non-Hispanic Black, non-Hispanic White, or Hispanic). Final analyses included 550 families (n=2230 eligible first-degree relatives) in the Family Heart Talk arm and 561 (n=2416) in the control arm. A higher percentage of eligible first-degree relatives completed screening in the Family Heart Talk arm (19.5% versus 16.0%), and the odds of screening completion among these first-degree relatives were higher in the Family Heart Talk arm after adjustment for proband randomization stratum, sex, and age quartile (odds ratio, 1.30 [1-sided 95% CI, 1.08-∞]). A prespecified subgroup analysis did not find evidence of heterogeneity in the adjusted intervention odds ratio across race/ethnicity strata (P=0.90). CONCLUSIONS: Family Heart Talk, a booklet that can be provided to patients with DCM by clinicians with minimal additional time investment, was effective in increasing cardiovascular clinical screening among first-degree relatives of these patients. REGISTRATION: URL: https://www. CLINICALTRIALS: gov; Unique identifier: NCT03037632.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Kinnamon DD, Jordan E, Haas GJ, et al. Effectiveness of the Family Heart Talk Communication Tool in Improving Family Member Screening for Dilated Cardiomyopathy: Results of a Randomized Trial. Circulation. 2023. PMID: 36938756. doi:10.1161/CIRCULATIONAHA.122.062507

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。